Cover Image

Clinicopathological significance and potential drug targeting of CDH1 in lung cancer: a meta-analysis and literature review

Qiaowen Yu,1 Qisen Guo,2 Liangan Chen,3 Shuwei Liu1 1Shandong Provincial Key Laboratory of Mental Disorders, Research Center for Sectional and Imaging Anatomy, Shandong University School of Medicine, 2Respiratory Medicine, Shandong Cancer Hospital, Jinan, 3Department of Respiratory Diseases, People&...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu Q (Author), Guo Q (Author), Chen L (Author), Liu S (Author)
Format:	Book
Published:	Dove Medical Press, 2015-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review
by: Huang R, et al.
Published: (2015)

The association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature review
by: Chen Q, et al.
Published: (2015)

The clinicopathological significance of CDH1 in gastric cancer: a meta-analysis and systematic review
by: Zeng W, et al.
Published: (2015)

Comments on a meta-analysis and systematic review of the clinicopathological significance of CDH1 in gastric cancer
by: Tu C, et al.
Published: (2016)

The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review
by: Su Y, et al.
Published: (2015)

Clinicopathological significance and potential drug target of RUNX3 in breast cancer
by: Yu YY, et al.
Published: (2014)

Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis
by: Xu L, et al.
Published: (2015)

Clinicopathological significance and potential drug target of T-cadherin in NSCLC
by: Wang Z, et al.
Published: (2014)

Clinicopathological significance and a potential drug target of RARβ in non-small-cell lung carcinoma: a meta-analysis and a systematic review
by: Song X, et al.
Published: (2016)

APC/C-Cdh1-targeted substrates as potential therapies for Alzheimer's disease
by: Rebeca Lapresa, et al.
Published: (2022)

Clinicopathological significance and potential drug target of p15INK4B in multiple myeloma
by: Li J, et al.
Published: (2014)

Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer
by: You Q, et al.
Published: (2015)

The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review
by: Wu X, et al.
Published: (2016)

Clinicopathological significance of CXCR4 in non-small cell lung cancer
by: Zhou X, et al.
Published: (2015)

New insights into congenital diaphragmatic hernia (CDH)- a surgeon's introduction to CDH animal models.
by: Priscilla Pui Lam Chiu
Published: (2014)

The CDH patient perspective journey
by: Beverley Power
Published: (2023)

Prognostic and clinicopathological significance of survivin in gynecological cancer
by: Agapiti H. Chuwa, et al.
Published: (2024)

Prognostic and Clinicopathological Significance of PD-L1 in Patients With Bladder Cancer: A Meta-Analysis
by: Lei Zhu, et al.
Published: (2019)

Prognostic and clinicopathological significance of Fusobacterium nucleatum in colorectal cancer: a systemic review and meta-analysis
by: Younghoon Kim, et al.
Published: (2022)

Unsolved problems in CDH follow-up
by: Laura Valfré, et al.
Published: (2022)

Prevalence and clinical significance of potential drug-drug interactions among lung transplant patients
by: Jiali Zhang, et al.
Published: (2024)

Clinicopathological significance of primitive phenotypes in early gastric cancer with differentiated histology
by: Zhi-Yi Zhou, et al.
Published: (2021)

Prenatal diagnosis of a familial 5p14.3-p14.1 deletion encompassing CDH18, CDH12, PMCHL1, PRDM9 and CDH10 in a fetus with congenital heart disease on prenatal ultrasound
by: Chih-Ping Chen, et al.
Published: (2018)

Clinicopathological significance of matrix metalloproteinase-7 protein expression in esophageal cancer: a meta-analysis
by: Miao S, et al.
Published: (2015)

Role of practice standardization in outcome optimization for CDH
by: Robert Baird, et al.
Published: (2024)

Expression and clinicopathological significance of antiapoptotis protein survivin in gallbladder cancer
by: Vishal Gupta, et al.
Published: (2016)

Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis
by: Qinfen Xie, et al.
Published: (2020)

Successful on-ECLS Repair of CDH and Omphalocele in a Newborn
by: Fideler Fideler, et al.
Published: (2023)

A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer
by: Zhang C, et al.
Published: (2015)

Low expression of E-Cadherin and Cdh1 variants associated with diffuse gastric cancer
by: Azaria García-Ruvalcaba, et al.
Published: (2023)

Clinicopathologic significance of DNA mismatch repair protein status in endometrial cancer
by: Ju-Hyun Kim, et al.
Published: (2022)

Clinicopathologic significance of mismatch repair protein expression in endometrioid endometrial cancer
by: Mi-Kyung Kim, et al.
Published: (2023)

MicroRNA-552 expression in colorectal cancer and its clinicopathological significance
by: Joon Im, et al.
Published: (2021)

Non-casual Association Between Congenital Pulmonary Airway Malformations/Primary Lung Hypoplasia and Congenital Diaphragmatic Hernia (CDH)
by: Gloria Pelizzo, et al.
Published: (2020)

Bioinformatics analysis of the clinicopathological and prognostic significance of BAG3 mRNA in gynecological cancers
by: Zi-mo Wang, et al.
Published: (2023)

The bioinformatics analysis of the clinicopathological and prognostic significances of REG4 mRNA in gynecological cancers
by: Cong-yu Zhang, et al.
Published: (2023)

Clinical significance of DAPK promoter hypermethylation in lung cancer: a meta-analysis
by: Li Y, et al.
Published: (2015)

The emerging role and clinicopathological significance of MFSD12 in cancer and lysosomal storage diseases
by: Liqiong Ding
Published: (2024)

Amrubicin: potential in combination with cisplatin or carboplatin to treat small-cell lung cancer
by: Ding Q, et al.
Published: (2013)

Biosynthetic Nanobubble-Mediated CRISPR/Cas9 Gene Editing of Cdh2 Inhibits Breast Cancer Metastasis
by: Ruru Gao, et al.
Published: (2022)